Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST).
Dent Mater J. 2022 Feb 1;41(1):142-149. doi: 10.4012/dmj.2021-155. Epub 2021 Sep 23.
This study examined the controlled release of cetylpyridinium chloride (CPC) from a tissue conditioner (TC) containing CPC-montmorillonite (CPC-Mont), the associated antimicrobial activity, and oral mucosa irritation. The CPC release test was performed daily for 28 days in three test solutions: distilled water, 0.2 M NaCl, and 0.2 M HCl. The antimicrobial activities for 7, 14, 21, and 28 days against Candida albicans, Staphylococcus aureus, and Streptococcus mutans were assessed according to the JIS Z 2801/ISO 22196 standard. An oral mucosa irritation test was conducted using cheek pouches in five male hamsters according to the ISO 10993-10:2010 standard. The amount of CPC released each day and the cumulative amount released over 28 days (6.12 mg) were less than the daily safe maximum of sore throat medicines (8 mg). Additionally, TC with CPC-Mont could sustain antimicrobial activity against adherent bacteria for 14 days and has no oral mucosa irritation potential.
本研究考察了载有十六烷基吡啶氯(CPC)的牙用调拌剂(TC)中 CPC 的控制释放、相关抗菌活性和口腔黏膜刺激性。将 CPC 释放试验在三种测试溶液(蒸馏水、0.2 M NaCl 和 0.2 M HCl)中每天进行 28 天。根据 JIS Z 2801/ISO 22196 标准,评估了 CPC 对白色念珠菌、金黄色葡萄球菌和变形链球菌的 7、14、21 和 28 天的抗菌活性。根据 ISO 10993-10:2010 标准,在五只雄性仓鼠的颊囊中进行了口腔黏膜刺激性试验。每天释放的 CPC 量和 28 天内(6.12 毫克)释放的累积量(6.12 毫克)均低于喉咙痛药物的每日安全最大剂量(8 毫克)。此外,载有 CPC-Mont 的 TC 可以对附着细菌持续抗菌活性 14 天,且无口腔黏膜刺激性。